Surgery Plus Chemo Better for Treating Relapsed Ovarian Cancer

The most favorable outcome was seen for patients with a complete resection, with a median overall survival of 61.9 months.

Related Keywords

Germany ,Kliniken Essen Mitte ,Philipp Harter ,Glaxosmithkline ,Healthday News ,New England Journal ,Arbeitsgemeinschaft Gyn ,